Drug Abuse Policy Functions

This executive order assigns drug abuse policy functions to the Office of Policy Development within the Executive Office of the President, designates the National Drug Policy Board to direct activities under the Drug Abuse Prevention, Treatment, and Rehabilitation Act, and revokes the previous Executive Order 12133.

47 FR 27843

No PDF available for this document.

Key directives

Assign Office of Policy Development to assist President and National Drug Policy Board in drug policy functions under 21 U.S.C. 1111
Designate Director of Drug Abuse Policy Office as primarily responsible for assisting President and Board
Designate National Drug Policy Board to direct all activities under Title II of Drug Abuse Prevention, Treatment, and Rehabilitation Act per 21 U.S.C. 1112
Assign National Drug Policy Board responsibility for formulating policy and coordinating/overseeing international and domestic drug abuse functions by all Executive agencies
Assign Director of Drug Abuse Policy Office direct responsibility for drug policy staff activities
Revoke Executive Order 12133 of May 9, 1979

Who is ordered

Timeline

Immediate

Revocation of Executive Order 12133
Assignment of drug policy functions to Office of Policy Development

Near term (90d)

Operational transition of drug policy staff under new Director

Long term

Ongoing coordination of international and domestic drug abuse functions across Executive agencies

Risks & tensions

Potential coordination tension between Office of Policy Development and National Drug Policy Board given dual assistance roles to the President
Scope of 'international as well as domestic drug abuse functions' is broad and could create overlap with State Department and foreign policy apparatus
Revocation of prior EO without explicit transition provisions may create administrative confusion
Subsequent amendment by EO 12590 (1987) indicates structural adjustments were needed, suggesting initial design had implementation challenges